H. Robert Superko - Concepedia

Author

H. Robert Superko

Also Known As

H R Superko, H ROBERT SUPERKO, H Robert Superko, H SUPERKO, H. R. SUPERKO, H. R. Superko, H. ROBERT SUPERKO, H. Robert Superko, H. Robert Superko, MD, FACC, H. Superko

176

Publications

6.1K

Citations

H-Index

Concepts

All Affiliations

Stanford University University of California, Berkeley Lawrence Berkeley National Laboratory Tufts University Piedmont Atlanta Hospital

About

H. Robert Superko is an author at Stanford University specializing in medicine, cardiovascular disease, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	33	1.6K
2	Public Health	13	15	541
3	Health Sciences	11	11	351
4	Biochemistry	5	5	255
5	Applied Physiology	2	2	31

H. Robert Superko

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). William L. Haskell, Edwin L. Alderman, Joan M. Fair, Circulation	1994	882
Changes in Plasma Lipids and Lipoproteins in Overweight Men during Weight Loss through Dieting as Compared with Exercise Peter D. Wood, Marcia L. Stefanick, Darlene M. Dreon, New England Journal of Medicine	1988	684
Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia Robert H. Knopp, Michael Davidson, Anne C. Goldberg, Metabolism PharmacologyPharmacotherapyTime-release FormMedicineEquivalent Efficacy	1998	238
Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia∗∗See Appendix for list of principal investigators, study sites, and laboratory sites. John R. Guyton, Anne C. Goldberg, Robert A Kreisberg, The American Journal of Cardiology Lipid DisorderLaboratory SitesCardiovascular DiseaseHypercholesterolemia∗∗see AppendixPharmacology	1998	206
Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD Fernando Bril, John J. Sninsky, Arthur M. Baca, The Journal of Clinical Endocrinology & Metabolism	2015	166
Differential effects of nicotinic acid in subjects with different LDL subclass patterns H. Robert Superko, Ronald M. Krauss Atherosclerosis Tobacco ControlDifferential EffectsMedicineNicotineNeuropharmacology	1992	132
Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo Samia Mora, Michael P. Caulfield, Jay G. Wohlgemuth, Circulation	2015	117
Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a) H. Robert Superko, Ronald M. Krauss Journal of the American College of Cardiology Food ChemistryNutritionLipid AnalysisBiochemistryLipid Nutrition	2000	116
Effect of a Diet High in Monounsaturated Fat From Almonds on Plasma Cholesterol and Lipoproteins Gene A. Spiller, David J.A. Jenkins, Liz N. Cragen, Journal of the American College of Nutrition Food ChemistryNutritionLipid NutritionOmega-3 Fatty AcidAlmond Oil	1992	114
Influence of symptomatic status on the prevalence of obstructive coronary artery disease in patients with zero calcium score Kamran Akram, Robert E. O’Donnell, Spencer B. King, Atherosclerosis Symptomatic StatusCardiovascular EpidemiologyCardiovascular DiseaseAcute Myocardial InfarctionCalcium Score	2008	89

Page 1